- Home
- CCEL vs NCSM Comparison
CCEL vs NCSM Comparison
Compare CCEL & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- NCSM
- Stock Information
- Founded
- CCEL 1989
- NCSM 2006
- Country
- CCEL United States
- NCSM United States
- Employees
- CCEL N/A
- NCSM N/A
- Industry
- CCEL Managed Health Care
- NCSM Oilfield Services/Equipment
- Sector
- CCEL Health Care
- NCSM Energy
- Exchange
- CCEL Nasdaq
- NCSM Nasdaq
- Market Cap
- CCEL 50.0M
- NCSM 51.9M
- IPO Year
- CCEL 1997
- NCSM 2017
- Fundamental
- Price
- CCEL $7.79
- NCSM $23.60
- Analyst Decision
- CCEL
- NCSM
- Analyst Count
- CCEL 0
- NCSM 0
- Target Price
- CCEL N/A
- NCSM N/A
- AVG Volume (30 Days)
- CCEL 12.6K
- NCSM 13.4K
- Earning Date
- CCEL 12-31-2024
- NCSM 10-30-2024
- Dividend Yield
- CCEL 3.19%
- NCSM N/A
- EPS Growth
- CCEL N/A
- NCSM N/A
- EPS
- CCEL N/A
- NCSM 16.77
- Revenue
- CCEL $31,838,476.00
- NCSM $152,801,000.00
- Revenue This Year
- CCEL $3.97
- NCSM $13.26
- Revenue Next Year
- CCEL $0.91
- NCSM $6.32
- P/E Ratio
- CCEL N/A
- NCSM $1.41
- Revenue Growth
- CCEL 1.95
- NCSM 3.66
- 52 Week Low
- CCEL $4.47
- NCSM $14.47
- 52 Week High
- CCEL $9.50
- NCSM $28.73
- Technical
- Relative Strength Index (RSI)
- CCEL 43.85
- NCSM 46.51
- Support Level
- CCEL $7.60
- NCSM $24.52
- Resistance Level
- CCEL $9.10
- NCSM $28.73
- Average True Range (ATR)
- CCEL 0.25
- NCSM 1.65
- MACD
- CCEL -0.14
- NCSM -0.34
- Stochastic Oscillator
- CCEL 15.08
- NCSM 5.18
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc provides products and support services that facilitate the optimization of oil and natural gas well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's primary offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. Geographically, majority of revenue is generated from United States.